30 Jul 2020 --- Cannabidiol (CBD) products company CV Sciences is strategically expanding into the category of condition specific dietary supplements with the launch of CV Acute. The product is touted as supporting the immune system and respiratory health and is the first of several to be launched under the company’s immunity line. This space is seeing rapid expansion due to COVID-19-related health concerns. Traditionally active in CBD, CV Sciences’ move toward immunity is expected to open new markets and sales channels, including major e-commerce retailers not currently accessible by CBD-related products.
